Oxford Biosensors Administration
The company has developed unique technology for point-of-care electro chemical testing for lipids and other analytes, for use in the cholesterol, diabetes and renal function diagnostic testing markets.
Information
| Appointment date | 8 June 2009 |
|---|---|
| Branches / stores | 1 |
| Insolvency Practitioners | Ian Cadlock and Andrew Pear |
